IKOMED Technologies Inc.
Verified IntelIKOMED is Vancouver-based medical-device Technology Company. Our AEGIS is a shutter system that incorporates machine learning and image processing to reduce X-ray radiation in fluoroscopy by over 60% as proven in clinical-studies. Fluoroscopy is an X-Ray based imaging technology widely used to guide minimally-invasive procedures where catheters are inserted into patients’ bodies for treatment. These procedures reduce the need for surgery but expose patients and staff to large amounts of radiation. AEGIS has been cleared by the FDA and is sold commercially in the USA via a partner. ATMOS is a proprietary device for non-invasive treatment of emphysema, a type of COPD (Chronic- Obstructive-Pulmonary-Disease) using RF radiation. Emphysema is a debilitating disease, caused by smoking and other factors, and is one of the leading causes of death worldwide. Treatment is focused on alleviating symptoms with no cure available. The ATMOS device provides a full cure for the disease. It has been successfully proven on rodents, in collaboration with the UBC center for Heart and Lung Innovation (HLI) under the leadership of Prof Don Sin, and is now being tested on large animals on path to human trials.
IKOMED is Vancouver-based medical-device Technology Company. Our AEGIS is a shutter system that incorporates machine learning and image processing to reduce X-ray radiation in fluoroscopy by over 60% as proven in clinical-studies. Fluoroscopy is an X-Ray based imaging technology widely used to guide minimally-invasive procedures where catheters are inserted into patients’ bodies for treatment. These procedures reduce the need for surgery but expose patients and staff to large amounts of radiation. AEGIS has been cleared by the FDA and is sold commercially in the USA via a partner. ATMOS is a proprietary device for non-invasive treatment of emphysema, a type of COPD (Chronic- Obstructive-Pulmonary-Disease) using RF radiation. Emphysema is a debilitating disease, caused by smoking and other factors, and is one of the leading causes of death worldwide. Treatment is focused on alleviating symptoms with no cure available. The ATMOS device provides a full cure for the disease. It has been successfully proven on rodents, in collaboration with the UBC center for Heart and Lung Innovation (HLI) under the leadership of Prof Don Sin, and is now being tested on large animals on path to human trials.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Privately Held
- Founded
- 2011
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 1375 McLean Dr British Columbia Vancouver
- City
- Vancouver
- Region / State
- British Columbia
- Postal Code
- —
- Country
- Canada
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for IKOMED Technologies Inc..